Trial NCT00669669

View at ClinicalTrials.gov 
Org. Study IDs: 2000.00
Secondary IDs: 2000.00 8357 NCI-2013-00701 RG1709046

Last trial update was posted on 2022-05-18

MeSH Interventions

Carmustine Lenograstim O(6)-benzylguanine Plerixafor Temozolomide

MeSH Conditions

Glioblastoma Glioma Gliosarcoma

Other Conditions


Stopping Reasons

Terminated due to loss in funding.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID